Sionna Therapeutics

Last updated: November 16, 2025
CEO Mike Cloonan
CEO Mike Cloonan
Country: USA | Funding: $292M (+)
Founded: 2018

Website: https://www.sionnatx.com/

Sionna’s batch of small molecules will be the first to fully restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein




Competitors